×
About 9,029 results

ALLMedicine™ Angina Pectoris Center

Research & Reviews  3,203 results

Evaluation of non-invasive imaging parameters in coronary microvascular disease: a syst...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789672
BMC Medical Imaging; Groepenhoff F, Klaassen RGM et. al.

Jan 7th, 2021 - Coronary microvascular dysfunction (CMD) is an important underlying cause of angina pectoris. Currently, no diagnostic tool is available to directly visualize the coronary microvasculature. Invasive microvascular reactivity testing is the diagnost...

Clinical significance of microvessels detected by in vivo optical coherence tomography ...
https://doi.org/10.1007/s00380-020-01756-0
Heart and Vessels; Nishida T, Hiro T et. al.

Jan 6th, 2021 - The significance of microvessels within atherosclerotic plaques is not yet fully clarified. Associated with plaque vulnerability. The aim of this study is to examine tissue characteristics of plaque with microvessels detected by optical coherence ...

Predictors of treatment benefits after enhanced external counterpulsation in patients w...
https://doi.org/10.1002/clc.23516
Clinical Cardiology REFERENCES; Wu E, Mårtensson J et. al.

Jan 5th, 2021 - Enhanced external counterpulsation (EECP) is a noninvasive treatment that can decrease limiting symptoms in patients with refractory angina pectoris (RAP). Identifying responders to EECP is important as EECP is not widely available and relatively ...

Increased short-term risk of cardiovascular events in inflammatory rheumatic diseases: ...
https://doi.org/10.1007/s00296-020-04754-7 10.1093/eurheartj/ehx628 10.1161/CIR.0000000000000659 10.1093/eurheartj/ehw106 10.1161/CIR.0000000000000678 10.1186/s12916-019-1340-7 10.1016/S0140-6736(13)61752-3 10.1038/s41569-019-0202-5 10.1016/S2214-109X(19)30365-1 10.1161/01.cir.97.18.1837 10.23880/OAJC-16000124 10.1111/j.1541-9215.2007.06350.x 10.1136/annrheumdis-2014-206879 10.1016/j.amjcard.2012.03.044 10.3899/jrheum.190261 10.1136/annrheumdis-2016-209775 10.1007/s00296-016-3619-8 10.1007/s00296-018-4053-x 10.1038/nrrheum.2015.112 10.1136/annrheumdis-2013-204531 10.1136/annrheumdis-2014-206411 10.1371/journal.pone.0205506 10.1186/s13075-020-02178-z 10.1093/rheumatology/kex038 10.1002/art.1780400928 10.1136/ard.2010.138461 10.1136/ard.2010.133645 10.1136/ard.38.5.434 10.2307/2529990 10.1136/annrheumdis-2014-205675 10.1136/annrheumdis-2016-210973 10.1093/rheumatology/kew475 10.1016/j.reuma.2017.06.002 10.1093/oxfordjournals.aje.a009122 10.3899/jrheum.180726 10.1136/ard.2008.094151 10.1007/s00296-020-04691-5 10.1002/acr.23875 10.1016/S0140-6736(18)30664-0 10.1136/rmdopen-2015-000166 10.1023/B:EJEP.0000036568.02655.f8
Rheumatology International; Da Silva Domingues V, Rodrigues AM et. al.

Jan 3rd, 2021 - Cardiovascular diseases represent the first cause of death globally. Inflammatory rheumatic disease (IRMD) patients, due to their lifelong inflammatory status, are at increased risk of developing premature cardiovascular disease. We aimed to asses...

Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Pa...
https://doi.org/10.1016/j.amjcard.2020.12.065
The American Journal of Cardiology; Martínez-Sánchez C, Azar-Manzur F et. al.

Jan 1st, 2021 - Extracorporeal shockwave myocardial revascularization (ESMR) is a therapy for refractory angina pectoris. Our aim was to assess the efficacy and safety of ESMR in the management of patients with stable coronary artery disease (CAD) and heart failu...

see more →

Guidelines  5 results

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

Recommendations for advancing the care of Canadians living with refractory angina pecto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.

Jul 8th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,

Resting Heart Rate in Cardiovascular Disease
https://www.sciencedirect.com/science/article/pii/S0735109707018232
Journal of the American College of Cardiology;

Dec 11th, 2006 - The importance of resting heart rate (HR) as a prognostic factor and potential therapeutic target is not yet generally accepted. Recent large epidemiologic studies have confirmed earlier studies that showed resting HR to be an independent predicto...

KAPSPARGO SPRINKLE (metoprolol succinate)
https://www.kapspargosprinklerx.com

Kapspargo Sprinkle™ extended-release capsules are for the treatment of hypertension, angina pectoris, and heart failure. Learn more here.

see more →

Drugs  1,249 results see all →

Clinicaltrials.gov  4,495 results

Propranolol hydrochloride - propranolol hydrochloride capsule, extended release-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0241448-5727-4c68-ae2a-6f41cd962d7c

Jan 13th, 2021 - Propranolol Hydrochloride Extended-Release Capsules, USP, are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochlorid...

Metoprolol tartrate - metoprolol tartrate tablet, film coated-RedPharm Drug, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89178e8c-2bf4-811b-e053-2995a90a6070

Jan 13th, 2021 - Metoprolol tartrate tablets, USP are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Metoprolol tartrate tablets, USP are indicated in the long-term treatment of angina pect...

Isosorbide dinitrate - isosorbide dinitrate tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac7fdd46-a27b-411d-9916-5a5f3bd72f1c

Jan 13th, 2021 - Isosorbide Dinitrate Tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in abo...

Metoprolol tartrate - metoprolol tartrate tablet, film coated-Preferred Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b51722e-6ed8-4a90-9725-5e5927bb261c

Jan 12th, 2021 - Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treat...

Metoprolol succinate - metoprolol succinate tablet, extended release-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8cf19ff-65fa-7044-e053-2a95a90a7a30

Jan 12th, 2021 - Metoprolol succinate, is a beta 1-selective adrenoceptor blocking agent. Metoprolol succinate extended-release tablets, USP are indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fata...

see more →

News  73 results

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.staging.medscape.com/viewarticle/939965

Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.medscape.com/viewarticle/939965

Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Cognitive Decline May Accelerate After Ischemic Events
https://www.medscape.com/viewarticle/914656

Jun 18th, 2019 - After a diagnosis of myocardial infarction (MI) or angina pectoris, individuals enrolled in the English Longitudinal Study of Aging (ELSA) showed more accelerated cognitive decline than those who remained free of coronary heart disease (CHD). The ...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

see more →

Patient Education  4 results see all →